Literature DB >> 7808615

Sympathetic mediation of peripheral vasodilation induced by spinal cord stimulation: animal studies of the role of cholinergic and adrenergic receptor subtypes.

B Linderoth1, P Herregodts, B A Meyerson.   

Abstract

Electric spinal cord stimulation (SCS) is widely used as a treatment modality for ischemic pain in peripheral arterial insufficiency. The background for the therapeutic effect may be a temporary inhibition of sympathetically maintained peripheral vasoconstriction. In this series of experiments, the involvement of different types of cholinergic and adrenergic receptor subclasses in the vasodilatory effect was explored in anesthetized rats. The microcirculation in hindlimb skin and hamstring muscle was studied by the laser Doppler technique. The ganglionic blocker hexamethonium as well as the nicotinic receptor antagonist chlorisondamine abolished the effect in both vascular beds, whereas the muscarinic receptor antagonists pirenzepine and atropine were ineffective. Among the adrenergic receptor active compounds, phentolamine, prazosine (an alpha 1-receptor antagonist), and clonidine in high doses suppressed the SCS-induced vasodilation. Yohimbine (an alpha 2-receptor antagonist) did not alter the effect. The beta-adrenergic compounds had a differential effect on muscle and skin perfusion. Atenolol, a beta 1-receptor antagonist, inhibited SCS-induced vasodilation only in the skin, whereas the beta 2-receptor antagonist butoxamine selectively depressed the muscle response. The vasodilatory effect of SCS in the animal model used here seems to a large extent to be mediated by an inhibitory effect on peripheral vasoconstriction maintained via efferent sympathetic activity involving nicotinic transmission in the ganglia and the postganglionic alpha 1-adrenoreceptors. The involvement of beta-receptors seems to be different in skin and muscle, beta 1 being more important for the changes in the skin and beta 2 being more important for those in muscle. The high-intensity antidromic response, earlier believed to explain how SCS exerted its vasodilatory effect, was resistant to cholinergic and adrenergic manipulations and seems to depend on entirely different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808615     DOI: 10.1227/00006123-199410000-00018

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  14 in total

1.  Urgent cesarean section in a patient with a spinal cord stimulator: implications for surgery and anesthesia.

Authors:  Suhas Patel; Samita Das; Robin B Stedman
Journal:  Ochsner J       Date:  2014

2.  Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.

Authors:  Stephen F Rodrigues; Edward D Tran; Zuleica B Fortes; Geert W Schmid-Schönbein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

3.  Prokinetic effects of spinal cord stimulation and its autonomic mechanisms in dogs.

Authors:  Bo Zhang; Feng Ji; Lei Tu; Yi Yang; Jiande D Z Chen
Journal:  Neurogastroenterol Motil       Date:  2019-04-14       Impact factor: 3.598

Review 4.  Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?

Authors:  Zaman Mirzadeh; Chelsea L Faber; Michael W Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2022-01-06       Impact factor: 13.820

5.  Extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS)-induced vasodilation.

Authors:  Mingyuan Wu; Naoka Komori; Chao Qin; Jay P Farber; Bengt Linderoth; Robert D Foreman
Journal:  Brain Res       Date:  2008-01-12       Impact factor: 3.252

6.  Femoral vascular conductance and peroneal muscle sympathetic nerve activity responses to acute epidural spinal cord stimulation in humans.

Authors:  Seth W Holwerda; Marshall T Holland; Chandan G Reddy; Gary L Pierce
Journal:  Exp Physiol       Date:  2018-05-05       Impact factor: 2.969

Review 7.  Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies.

Authors:  Mingyuan Wu; Bengt Linderoth; Robert D Foreman
Journal:  Auton Neurosci       Date:  2008-02-29       Impact factor: 3.145

8.  Roles of peripheral terminals of transient receptor potential vanilloid-1 containing sensory fibers in spinal cord stimulation-induced peripheral vasodilation.

Authors:  Mingyuan Wu; Naoka Komori; Chao Qin; Jay P Farber; Bengt Linderoth; Robert D Foreman
Journal:  Brain Res       Date:  2007-04-30       Impact factor: 3.252

9.  Electrical modulation of the sympathetic nervous system in order to augment cerebral blood flow: a protocol for an experimental study.

Authors:  Mark Ter Laan; J Marc C van Dijk; Michiel J Staal; Jan-Willem J Elting
Journal:  BMJ Open       Date:  2011-07-22       Impact factor: 2.692

10.  Spinal cord stimulation in pain management: a review.

Authors:  Young Hoon Jeon
Journal:  Korean J Pain       Date:  2012-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.